Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hepatitis

Chronic HCV infection, diabetes and liver-related outcomes

There is increasing interest in the role that diabetes has in liver-related outcomes in patients with chronic HCV. Elkrief and colleagues have furthered this discussion by indicating that diabetes may be considered a prognostic factor for major liver-related outcomes in patients with chronic HCV infection, including death and transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology http://dx.doi.org/10.1002/hep.27228 (2014).

  2. Stepanova, M., Lam, B., Younossi, Y., Srishord, M. K. & Younossi, Z. M. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J. Viral Hepat. 19, 341–345 (2012).

    Article  CAS  Google Scholar 

  3. Younossi, Z. M., Stepanova, M., Nader, F., Younossi, Z. & Elsheikh, E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment. Pharmacol. Ther. 37, 647–652 (2013).

    Article  CAS  Google Scholar 

  4. Kiran, Z. et al. Insulin resistance in non-diabetic patients of chronic Hepatitis C. Pak. J. Med. Sci. 29, 201–204 (2013).

    PubMed  PubMed Central  Google Scholar 

  5. Miyajima, I. et al. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: A population-based study in an HCV hyperendemic area. J. Gastroenterol. 48, 93–100 (2013).

    Article  Google Scholar 

  6. Arase, Y. et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 49, 739–744 (2009).

    Article  CAS  Google Scholar 

  7. Aghemo, A. et al. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. Hepatology 56, 1681–1687 (2012).

    Article  CAS  Google Scholar 

  8. Kawaguchi, Y. & Mizuta, T. Interaction between hepatitis C virus and metabolic factors. World J. Gastroenterol. 20, 2888–2901 (2014).

    Article  Google Scholar 

  9. Moucari, R. et al. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C. Gut 59, 1694–1698 (2010).

    Article  CAS  Google Scholar 

  10. Sersté, T. et al. Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity. Liver Int. 30, 1131–1136 (2010).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zobair Younossi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Henry, L., Younossi, Z. Chronic HCV infection, diabetes and liver-related outcomes. Nat Rev Gastroenterol Hepatol 11, 520–521 (2014). https://doi.org/10.1038/nrgastro.2014.122

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2014.122

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing